USA Uranium Corporation, a U.S.-based technology company, will be changing the company’s name to USA Advanced Tech Inc. The new name will more accurately reflect the emphasis that the company is placing on its technical division, particularly as it devotes additional resources to the completion of the MyScreenMD.com online medical technologies project. The company’s website will be changed to www.USAAdvancedTech.com.
The company also added Dr. William Blase to the board in order to further assist with the development of the MyScreenMD project, as well as serve on its medical/technical advisory board. Throughout his distinguished career, Dr. Blase has been involved in all aspects of the medical profession, with a practice emphasis on ophthalmology and administration and management issues of modern medical practice, especially dealing with state and federal medical administrative/service organizations, insurance companies and drug companies – skills which will be of enormous value as the MyScreenMD project proceeds.
USA Advanced Tech is focused on reviewing, developing and acquiring technologies that will benefit the medical community, including the recently acquired technology known as the MyScreenMD. The MyScreenMD program is an Internet-based, home medical diagnostic and testing software that utilizes a screen-based Internet access device in partnership with the medical community. According to the company, the primary benefits of the MyScreenMD.com model offers patients superior outcomes, better satisfaction, and significantly lower costs.
The company intends to offer their services and products in conjunction with participating physicians, who will receive significant benefits from their participation. The company also believes that – through their joint venture relationships and strategic alliances – they have positioned themselves to become the nation’s leading provider of Internet-based medical diagnostic and testing products utilizing screen-based Internet access devices to reach the ever-growing market segment requiring access to instant medical testing and electronic diagnosis” products.
Let us hear your thoughts below: